ELISA 분석기 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 기술별, 최종사용자별, 검사 유형별, 측정 모드별, 지역별 - 업계 예측(2026-2033년)

Global Elisa Analyzers Market size was valued at USD 735.5 Million in 2024 and is poised to grow from USD 766.39 Million in 2025 to USD 1065.1 Million by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global market for ELISA analyzers, encompassing both automated and semi-automated platforms for biomarker measurement, is propelled by rising demands for efficient and standardized diagnostic testing. These analyzers play a crucial role in clinical labs, pharmaceutical research, and blood banks, facilitating reliable outcomes in areas such as infectious disease screening, oncology monitoring, and vaccine development. The shift from manual methods to sophisticated robotic workflows enhances productivity, particularly among large hospital networks. Technological advancements, including multiplex assay support and LIMS interoperability, allow laboratories to manage increased sample volumes and share critical data for epidemiological purposes. The trend towards smaller, cost-effective bench-top systems is also promoting wider adoption in Asia Pacific and Latin America, fostering collaborations that enhance public health initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elisa Analyzers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Elisa Analyzers Market Segments Analysis

Global elisa analyzers market is segmented by product type, application, technology, end user, test type, mode and region. Based on product type, the market is segmented into Open ELISA Analyzers, Closed ELISA Analyzers, Semi-Automated ELISA Analyzers, Fully Automated ELISA Analyzers and Others. Based on application, the market is segmented into Infectious Disease Testing, Oncology Testing, Immunology Testing, Hormone Testing, Drug Monitoring and Others. Based on technology, the market is segmented into Chemiluminescent ELISA, Fluorescent ELISA, Colorimetric ELISA, Multiplex ELISA and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on test type, the market is segmented into Sandwich ELISA, Competitive ELISA, Indirect ELISA and Direct ELISA. Based on mode, the market is segmented into Benchtop ELISA Analyzers and Portable ELISA Analyzers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Elisa Analyzers Market

The increasing demand for diagnostic testing across various healthcare environments is propelling the need for ELISA analyzers, which offer dependable immunoassays for identifying biomarkers, infectious agents, and immune responses. Automated systems are favored by clinical laboratories and research institutions due to their ability to maintain consistent throughput with reduced manual variability. This enhances workflow efficiency and allows for a broader test menu implementation. Healthcare providers emphasize the importance of early detection and comprehensive diagnostics, which fosters the acquisition of ELISA analyzers to meet clinical needs and ensure reproducible, high-quality testing results.

Restraints in the Global Elisa Analyzers Market

The high costs associated with ELISA analyzers present a significant barrier to market growth. The initial purchase price, coupled with expenses for proprietary reagents, calibration, and routine servicing, can deter smaller laboratories and clinics operating on tight budgets from acquiring these instruments. Such financial constraints may lead institutions to favor multipurpose equipment or outsource testing instead. Consequently, this limits market penetration in resource-constrained environments and hampers the adoption of newer technologies. Vendors face challenges in gaining widespread acceptance unless they develop flexible pricing models or implement strategies to reduce costs, thereby making these analyzers more accessible to a broader range of facilities.

Market Trends of the Global Elisa Analyzers Market

The Global ELISA Analyzers market is witnessing a transformative trend characterized by the miniaturization of assays and increased automation. Laboratories are increasingly adopting smaller-format assays, complemented by automated analyzers, which streamline workflows by requiring lower sample volumes and simplifying reagent management. Manufacturers are innovating with integrated microfluidic and cartridge-based designs that minimize manual interventions and reduce operator variability, enabling concurrent processing of multiple samples. This shift not only enhances scalability but also broadens the range of ELISA applications across point-of-care, clinical, and research environments, driving operational efficiency, expediting turnaround times, and ensuring reproducibility while prioritizing safety in laboratory settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global ELISA Analyzers Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Open ELISA Analyzers
• Closed ELISA Analyzers
• Semi-Automated ELISA Analyzers
• Fully Automated ELISA Analyzers
• Others

Global ELISA Analyzers Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Immunology Testing
• Hormone Testing
• Drug Monitoring
• Others

Global ELISA Analyzers Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Chemiluminescent ELISA
• Fluorescent ELISA
• Colorimetric ELISA
• Multiplex ELISA
• Others

Global ELISA Analyzers Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Global ELISA Analyzers Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Sandwich ELISA
• Competitive ELISA
• Indirect ELISA
• Direct ELISA

Global ELISA Analyzers Market Size by Mode & CAGR (2026-2033)

• Market Overview
• Benchtop ELISA Analyzers
• Portable ELISA Analyzers

Global ELISA Analyzers Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Technology, End User, Test Type, Mode)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User, Test Type, Mode)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User, Test Type, Mode)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User, Test Type, Mode)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User, Test Type, Mode)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Dynex Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTek Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Awareness Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynex Technologies Europe Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robonik India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Mannheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayto Life and Analytical Sciences Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Diagnostics Worldwide
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triturus Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations